Publications

5808 Results

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set [PMC2815708; PMID20008641]

Authors
A de Gramont;J Hubbard;Q Shi;M O'Connell;M Buyse;J Benedetti;B Bott;C O'Callaghan;G Yothers;RM Goldberg;CD Blanke;A Benson;Q Deng;S Alberts;T Andre;N Wolmark;A Grothey;D Sargent
Journal / Conference
Journal of Clinical Oncology 28(3):460-465
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Association of intratumoral gene expression levels of TP (thymidine phosphorylase) and VEGF are associated with clinical outcome in stage II/III rectal cancer patients treated with 5-fluorouracil (5-FU) and pelvic radiation in a phase III intergroup trial (SWOG 9304)

Authors
R Ladner;C Ulrich;C Rankin;K Danenberg;P Danenberg;SR Smalley;KW Makar;J Benedetti;CD Blanke;HJ Lenz
Journal / Conference
Journal of Clinical Oncology 28:7s, 2010 (suppl; abstr 3640); ASCO Annual Meeting; poster
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Human papillomavirus types 16, 18 and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial. PMC2820385; PMID: 20142255

Authors
S Sutcliffe;R Viscidi;C Till;P Goodman;A Hoque;A Hsing;IM Thompson;J Zenilman;A De Marzo;EA Platz
Journal / Conference
Cancer Epidemiology Biomarkers and Prevention 19(2):614-618
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Transparency and reproducibility in data analysis: The Prostate Cancer Prevention Trial. PMC2883301 PMID:20173101

Authors
S Baker;A Darke;P Pinsky;H Parnes;B Kramer
Journal / Conference
Biostatistics 11(3):413-418
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Effect of vitamin E and selenium on incidence of physician-diagnosed COPD: the Selenium and Vitamin E Cancer Prevention trial (SELECT)

Authors
P Cassano;K Arnold;K Guertin;A Kristal;J Crowley;J Hartline;P Goodman;C Tangen;L Minasian;S Lippman;C Coltman;E Klein
Journal / Conference
American Journal of Respiratory and Critical Care Medicine 181:A6765; Am Thoracic Soc Ann Meeting; oral
Year
2010
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000C

Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. PMID:19938041

Authors
A Kristal;DK Price;JM Schenk;M Neuhouser;S Ockers;DW Lin;WD Figg
Journal / Conference
Prostate 70(6):584-590
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies. PMID: 20135215

Authors
E Platz;S Sutcliffe;AM De Marzo;CG Drake;N Rifai;A Hsing;A Hoque;M Neuhouser;P Goodman;A Kristal
Journal / Conference
Cancer Causes and Control 21(6):847-851
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. PMC2842217;PMID:20142396

Authors
JM Schenk;AR Kristal;M Neuhouser;C Tangen;E White;DW Lin;M Kratz;IM Thompson
Journal / Conference
American Journal of Epidemiology 171(5):571-582
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy [PMID20024613]

Authors
J Sparano;ED Pisano;JR White;KK Hunt;EP Mamounas;E Perez;G Hortobagyi;JR Gralow;R Comis
Journal / Conference
Breast Cancer Research and Treatment 120(2):273-284
Year
2010
Research Committee(s)
Breast

Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328, a monoclonal antibody against interleukin-6 (IL-6), in chemotherapy pre-treated patients with castration-resistant prostate cancer (CRPC) [PMC2898710; PMID20484019]

Authors
T Dorff;B Goldman;J Pinski;P Mack;P Lara;P Van Veldhuizen;DI Quinn;N Vogelzang;IM Thompson;M Hussain
Journal / Conference
Clinical Cancer Research 16(11):3028-3034;
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
S0354